/
JCO 2008
Prospective phase II study with 70 patients
SBRT with very high irradiation doses of up to 3 x 22Gy
Freedom from ≥ grade 3 toxicity
peripheral
central
M Guckenberger - SBRT stage I NSCLC - HICARE 2015
20